T-Cell Immunotherapy Trial Could be Good News for Mesothelioma Patients
The first four mesothelioma patients treated with a new kind of T-cell immunotherapy have responded well with few side effects. …
-
-
Europe | International | Symptoms | Treatments | Updates
COPD Drug Might Help with Drooling in Pleural Mesothelioma Patients
A UK doctor says a drug used to treat COPD can help with drooling in pleural mesothelioma patients on palliative… -
Palliative Radiotherapy for Mesothelioma Faster with New Technology
A new type of linear accelerator could make palliative radiotherapy for mesothelioma faster and safer. That news comes from researchers… -
Quality of Life with Mesothelioma: Too Many Symptoms, Not Enough Support
A new study suggests that even the healthiest patients have a lower quality of life with mesothelioma than they should.… -
Non-Epithelioid Mesothelioma: Immunotherapy Combo Could be the New Standard of Care
Two immunotherapy drugs could become the new standard of care for people with non-epithelioid mesothelioma. All forms of malignant mesothelioma… -
Europe | International | New Studies | Research | Symptoms | Treatments
Decisions About Pleural Effusion in Mesothelioma: New Tool May Help
Researchers in the UK have developed a new tool that may help patients with mesothelioma and other pleural cancers make… -
Electrochemotherapy for Mesothelioma May Relieve Pain, Shrink Tumors
There’s new evidence that a technique called electrochemotherapy (ECT) may relieve mesothelioma pain and even shrink tumors. It may be… -
Triple Therapy May Become New First-Line Treatment for Mesothelioma
A combination of three powerful mesothelioma therapies could become a new first-line treatment for mesothelioma if an upcoming clinical trial… -
Common Drugs May Impact Mesothelioma Survival After Immunotherapy
There is new evidence that taking certain common drugs could negatively impact mesothelioma survival after immunotherapy. Drugs such as NSAIDs,… -
First-Line Immunotherapy May Be Better Than Chemo for This Mesothelioma Subtype
A new study suggests that people with sarcomatoid mesothelioma may fare better if they have first-line immunotherapy before considering chemotherapy. …
